Advertisement
Symptoms of COVID-19 are a poor marker for severe acute respiratory syndrome coronavirus 2 infection

Symptoms of COVID-19 Poor Marker for SARS-CoV-2 Infection

0
Only 13.9 percent of individuals with positive test reported specific symptoms on the day of the test
For U.S. adults with problem substance use who use nonmedical opioids

For Substance Abusers, Odds of Opioid Use Up With Cannabis Use

0
For adults using nonmedical opioids, odds of opioid use are increased on days when cannabis is used
Combined moderate- and high-intensity training has no effect on all-cause mortality compared with recommended physical activity levels

Exercise Intensity Seems Not to Impact Mortality Levels

0
Combined MICT, HIIT intervention group had no difference in mortality versus recommended guidelines
Disease course

Specific Factors Tied to Unemployment With MS Diagnosis

0
Many of the factors related to maintenance of employment are alterable
Racial disparities in insulin pump use among children with type 1 diabetes have persisted for 15 years

Disparities in Insulin Pump Use Persist, 2005 to 2019

0
Use higher among White children with type 1 diabetes versus Black and Hispanic children
Bedside open tracheotomy seems safe for critically ill patients with COVID-19

Bedside Tracheotomy Feasible for Critically Ill COVID-19 Patients

0
No infection identified among surgeons following procedure; postoperative complications rarely seen
Patients with type 2 diabetes are more likely to develop vascular dementia and nonvascular dementia compared with controls without diabetes

T2DM Links to Risk for Dementia Differ by Type, Glycemic Control

0
Dose-response association shows higher risk for dementia with HbA1c >87 versus <52 mmol/mol
COVID-19 deaths in the United States could reach 233

CDC: U.S. COVID-19 Deaths Could Reach 233,000 by End of October

0
And, dual coronavirus-flu vaccine to start human trials
For patients hospitalized with COVID-19

Remdesivir Cuts Time to COVID-19 Recovery

0
However, no significant difference in mortality found between remdesivir and placebo groups
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of Oct. 5 to 9

Physician’s Briefing Weekly Coronavirus Roundup

0
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...